Enrich your medicines pipeline

The research partner that creates innovative solutions, builds dynamic relationships and enriches your medicines pipeline across a range of human diseases

Our Services

Offerings

Research Phases

Therapeutic Areas

Target Classes

Approaches

Domainex provides a complete range of preclinical drug discovery services tailored to meet all your research needs.

Our Services

Case Studies

G9a: A FBDD programme to identify lysine methyltransferase inhibitors for the treatment of cancer

Domainex identified several highly efficient fragment hits and after one round of elaboration a 10-fold increase in affinity was achieved. View more

News

How can Domainex enrich your medicines pipeline?

14 Sep '20

Blog Post

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia.

14 Jul '20

Press Release

Enrich your medicines pipeline

The research partner that creates innovative solutions, builds dynamic relationships and enriches your medicines pipeline across a range of human diseases

Offerings

Research Phases

Therapeutic Areas

Target Classes

Approaches

Case Studies

MAP4K4: Kinase inhibitors for cardioprotection following heart attacks

Tankyrase: Inhibitors for the treatment of solid tumours

Der p 1: Protease Inhibitors for the treatment of asthma

TBK1/IKKε: Kinase inhibitors for the treatment of interferonopathies

FLIPP-FADD: PPI inhibitors for the treatment of solid tumours

Ras: PPI inhibitors for the treatment of cancer

G9a: Lysine Methyltransferase Inhibitors for the Treatment of Cancer

G9a: A FBDD programme to identify lysine methyltransferase inhibitors for the treatment of cancer

News

How can Domainex enrich your medicines pipeline?

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia.

Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman

Events

Oct 2 OBN Digital Event: Hosted by Domainex

Nov 19 31st Symposium on Medicinal chemistry in Eastern England

Jul 5 Kinase 2021

Tweets

Offerings

Research Phases

Therapeutic Areas

Target Classes

Approaches